Crossmark

Direct acting anti-hepatitis C combinations as potential COVID-19 protease inhibitors

Crossref DOI link: https://doi.org/10.1007/s13337-021-00691-6

Published Online: 2021-04-29

Published Print: 2021-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hamed, Mahmoud

El-Hasab, Mahmoud

Mansour, Fotouh R. https://orcid.org/0000-0003-0847-4035
License Information

Text and Data Mining valid from 2021-04-29

Version of Record valid from 2021-04-29
More Information

Article History

Received: 14 January 2021

Accepted: 17 April 2021

First Online: 29 April 2021

Free to read: This content has been made available to all.